Although an association between myelodysplastic syndrome (MDS) and autoimmune disorders is rather common, aortitis-associated MDS is very rare. 1, 2 Furthermore, a combination of chronic myelomonocytic leukemia and aortitis has not been reported. As a curative treatment, allogeneic hematopoietic stem cell transplantation has been conducted for patients with autoimmune disorders-associated MDS. However, allogeneic hematopoietic stem cell transplantation either for sole aortitis or for MDSassociated aortitis has not been reported.
A 32-year-old male was admitted because of fever, leukocytosis, and a high C-reactive protein in June 2004. Hematologic examination showed a white cell count of 30.3 Â 10 9 /l with 64% mature neutrophils and 17% monocytes, a hemoglobin concentration of 10.1 g/100 ml, and a platelet count of 515 Â 10 9 /l. C-reactive protein was elevated to 12.7 mg/100 ml (normally below 0.5 mg). A bone marrow aspirate showed granuloid and megakaryocytic hyperplasia without an increase in the myeloblast frequency. The karyotype was 46, XY. CT scanning and MR imaging showed wall thickening and deformity of the ascending aorta, aortic arch, and right common carotid artery ( Figure 1) , and, subsequently, a diagnosis of aortitis was made. To relieve the aortitis, a combination treatment with oral prednisolone (40 mg/day) and methotrexate (10 mg/week) was needed, while the leukocytosis persisted. In March 2006, the white cell count increased to 52.5 Â 10 9 /l with 2% myeloblasts and 10% monocytes. On this occasion, he was afebrile and showed a negative C-reactive protein with prednisolone (25 mg/day) and methotrexate (10 mg/week). The percentages of myeloblast and monocyte in the marrow cells were 3.2 and 15%, respectively, and trilineage dysplastic features were observed. The karyotype was 47, XY, þ 21 in 50% of dividing cells. An additional diagnosis of chronic myelomonocytic leukemia was made. Re-evaluation of the initial bone marrow preparation showed bilineage dysplastic features indicating the existence of chronic myelomonocytic leukemia in June 2004. He required frequent red blood cell transfusions from May 2006, and marked hepatosplenomegaly developed. After successful treatment with hydroxyurea, he underwent allogeneic bone marrow transplantation from an HLAmatched sibling donor in September 2006. The aortitis was controlled with same two agents before bone marrow transplantation. The conditioning regimen consisted of total body irradiation of 12 Gy and cyclophosphamide (60 mg/kg for 2 consecutive days). Cyclosporine A and short-term methotrexate were used for the prophylaxis of graft-versus-host disease (GVHD). Acute GVHD affecting the skin and then the liver developed on days 23 and 35, respectively. Total bilirubin elevated to 15.9 mg/100 ml. The simultaneous administration of intravenous methylprednisolone (2 mg/kg/day) and oral mycophenolate mofetil (1500 mg/day) relieved the severe liver dysfunction. Complete donor chimerism was confirmed on day 97 with well-controlled acute GVHD. All immunosuppressive agents were discontinued in May 2008.
In the treatment of refractory autoimmune disorders, allogeneic hematopoietic stem cell transplantation exhibits an effect, that is, graft versus autoimmunity. 3, 4 In the present patient, two factors may have contributed to the successful bone marrow transplantation. One was the intensive conditioning regimen that may have exhibited not only myeloablative but also potent immunosuppressive effects. The other was the severe GVHD in which donor lymphocytes may have eliminated the recipient's autoreactive cells.
